Related Experiment Video
Updated: May 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active
Enrico Cerrato1, Fabrizio D'Ascenzo, Giuseppe Biondi-Zoccai
1Division of Cardiology, Azienda Ospedaliera Cittá della Salute e della Scienza, Corso Bramante 88-90, 10126 Turin, Italy. enrico.cerrato@gmail.com
Insights
Cardiac dysfunction is common in human immunodeficiency virus (HIV) patients, even those with few symptoms. This meta-analysis highlights the prevalence of both systolic and diastolic left ventricular dysfunction in HIV-infected individuals.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Human immunodeficiency virus (HIV) infection is linked to cardiac dysfunction, impacting patient morbidity and mortality.
- Previous studies on HIV and cardiac issues were often conducted before the widespread use of highly active antiretroviral therapy (HAART).
Purpose of the Study:
- To conduct a comprehensive meta-analysis assessing the incidence of cardiac dysfunction in HIV-infected patients with minimal symptoms.
- To update the understanding of cardiac dysfunction in the era of HAART.
Main Methods:
- Systematic screening of Medline, Cochrane Library, and Biomed Central for relevant studies.
- Pooled analysis of data from 11 studies, including 2242 patients, using random effect methods.
- Appraisal of baseline treatment and cardiac imaging data.
Main Results:
- The incidence of left ventricular systolic dysfunction was 8.33% and diastolic dysfunction was 43.38%.
- Diastolic dysfunction was further categorized into first (31.85%), second (8.53%), and third degree (3.02%).
- Predictors for systolic dysfunction included high C-reactive protein, smoking, and prior myocardial infarction. Hypertension and older age predicted diastolic dysfunction.
Conclusions:
- Systolic and diastolic dysfunction are frequent findings in HIV-infected patients with few symptoms.
- Cardiac dysfunction occurs irrespective of whether patients are on HAART.
Aims:
Human immunodeficiency virus infection (HIV) has been associated with cardiac dysfunction that, if present, can negatively affect morbidity and mortality of HIV-infected patients. Unfortunately, many of the studies on this topic were performed before the highly active antiretroviral therapy (HAART) was established. Thus, we performed a comprehensive meta-analysis to critically appraise the incidence of cardiac dysfunction in HIV-infected pauci symptomatic patients.
Methods And Results:
Medline, Cochrane Library, and Biomed Central were systematically screened for studies reporting on systolic and/or diastolic dysfunctions in HIV pauci-symptomatic patients. Baseline treatment and cardiac imaging data were appraised and pooled with random effect methods computing summary. At pooled analysis, including a total of 2242 patients from 11 studies, an overall average incidence of traditional cardiovascular risk factors was observed, while a low rate of previous coronary artery disease was reported. Incidence of systolic and diastolic left ventricular dysfunction was 8.33% (95% CI: 2.20-14.25) and 43.38% (95% CI: 31.73-55.03), respectively. Diastolic dysfunction was graded as first [31.85% (95% CI: 24.85-43.73)], second [8.53% (95% CI: 2.12-14.93)], and third degree [3.02% (95% CI: 1.78-4.27)]. At multivariate analysis, a high sensitivity C-reactive protein level >5 mg/L, active tobacco smoking and previous history of myocardial infarction were predictors of left ventricular systolic dysfunction [odd ratio 1.70 (95% CI: 1.03-2.77); 1.57 (95% CI: 1.03-2.34); and 15.90 (95% CI: 1.94-329.00), respectively]. Hypertension (OR = 2.30; 95% CI: 1.20-4.50) and older age (OR = 2.50 per 10 years increase; 95% CI: 1.70-3.60) were predictors of left ventricular diastolic dysfunction (Figure 3).
Conclusions:
Systolic and diastolic dysfunction represent a common finding in pauci symptomatic HIV-infected patients, regardless to HAART.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

